X-151397349-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001017980.4(VMA21):c.41C>T(p.Pro14Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,161,719 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P14P) has been classified as Likely benign.
Frequency
Consequence
NM_001017980.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.41C>T | p.Pro14Leu | missense_variant | 1/3 | ENST00000330374.7 | |
VMA21 | NM_001363810.1 | c.218+292C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.41C>T | p.Pro14Leu | missense_variant | 1/3 | 1 | NM_001017980.4 | P1 | |
VMA21 | ENST00000370361.5 | c.218+292C>T | intron_variant | 5 | |||||
VMA21 | ENST00000477649.1 | n.133+702C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000882 AC: 1AN: 113349Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 35477
GnomAD4 exome AF: 0.0000162 AC: 17AN: 1048370Hom.: 0 Cov.: 30 AF XY: 0.0000175 AC XY: 6AN XY: 342380
GnomAD4 genome AF: 0.00000882 AC: 1AN: 113349Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 35477
ClinVar
Submissions by phenotype
X-linked myopathy with excessive autophagy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 533404). This variant has not been reported in the literature in individuals affected with VMA21-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 14 of the VMA21 protein (p.Pro14Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at